The company has entered into a binding term sheet with Stelis to acquire its Bengaluru-based Unit 3 biologics manufacturing unit, Syngene said in a late night statement on Tuesday.from Moneycontrol Business News https://ift.tt/r3R0maP
via IFTTT
Syngene to acquire plant from Stelis Biopharma for Rs 702 crore
July 04, 2023
0
The company has entered into a binding term sheet with Stelis to acquire its Bengaluru-based Unit 3 biologics manufacturing unit, Syngene said in a late night statement on Tuesday.from Moneycontrol Business News https://ift.tt/r3R0maP
via IFTTT
